RVNC - Revance Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
12/30/2018
12/30/2017
12/30/2016
Assets
Current Assets
Cash
Cash And Cash Equivalents
73,256
282,896
63,502
Short Term Investments
102,556
-
122,026
Total Cash
175,812
282,896
185,528
Net Receivables
27,000
48
75
Inventory
-
-
-
Other Current Assets
-
0
163
Total Current Assets
207,922
285,211
192,695
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
28,421
22,781
22,743
Accumulated Depreciation
-13,972
-13,531
-12,158
Net property, plant and equipment
14,449
9,250
10,585
Equity and other investments
-
-
0
Goodwill
-
-
-
Intangible Assets
-
-
-
Other long-term assets
3,977
1,238
1,080
Total non-current assets
18,426
10,488
11,665
Total Assets
226,348
295,699
204,360
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
-
-
-
Accounts Payable
8,434
6,805
3,754
Taxes payable
-
-
-
Accrued liabilities
14,948
12,225
12,418
Deferred revenues
8,588
-
-
Other Current Liabilities
541
710
661
Total Current Liabilities
31,970
20,902
19,647
Non-current liabilities
Long Term Debt
-
-
-
Deferred taxes liabilities
-
-
-
Deferred revenues
42,684
-
-
Other long-term liabilities
-
2,613
100
Total non-current liabilities
48,756
5,952
7,642
Total Liabilities
80,726
26,854
27,289
Stockholders' Equity
Common Stock
37
37
29
Retained Earnings
-684,775
-542,167
-421,543
Accumulated other comprehensive income
-8
-
-45
Total stockholders' equity
145,622
268,845
177,071
Total liabilities and stockholders' equity
226,348
295,699
204,360